The Blood Safety and Quality (Fees Amendment) Regulations 2009
S.I. 2009/372 · Made 23 February 2009
Fees And Charges
Health And Safety
Made 23rd February 2009
Laid before Parliament 3rd March 2009
Coming into force 1st April 2009
The Secretary of State has been designated for the purposes of section 2(2) of the European Communities Act 1972 in relation to health protection measures regulating the use of material of human originf3.
The Treasury has consented to the making of these Regulations as required by section 56(1) of the Finance Act 1973.
Annotations to the whole text
Footnotes
- f1
-
1972 c.68. Under section 57(1) of the Scotland Act 1998 (c.46), despite the transfer to Scottish Ministers of functions in relation to implementing obligations under Community law in relation to devolved matters, the functions of the Secretary of State in relation to implementing these obligations continues to be exercisable by the Secretary of State as regards Scotland.
- f2
- f3
Contents
- 1Citation, commencement and interpretation
- 2Amendment of regulation 22 of the principal Regulations
- Signature
- Explanatory note
1Citation, commencement and interpretation
These Regulations may be cited as the Blood Safety and Quality (Fees Amendment) Regulations 2009 and shall come into force on 1st April 2009.
In these Regulations “the principal Regulations” means the Blood Safety and Quality Regulations 2005f1.
2Amendment of regulation 22 of the principal Regulations
Regulation 22 of the principal Regulations (fees) is amended as follows.
In paragraph (2)—
in sub-paragraph (a), for “£2,927” substitute “£3,044”;
in sub-paragraph (b), for “£493” substitute “£513”; and
in sub-paragraph (c), for “£440” substitute “£458”.
In paragraph (2A), in sub-paragraph (b) for “£468” substitute “£487”.
In paragraph (3)—
in sub-paragraph (a), for “£2,452” substitute “£2,557”; and
in sub-paragraph (b), for “£1,226” substitute “£1,279”.
In paragraph (3A), for “£650” substitute “£676”.
In paragraph (3C)(c), for “£468” substitute “£487”.
In paragraph (5)—
in sub-paragraph (a), for “£2,452” substitute “£2,557”; and
in sub-paragraph (b), for “£1,226” substitute “£1,279”.
In paragraph (5B)—
in sub-paragraph (a), for “£2,452” substitute “£2,557”; and
in sub-paragraph (b), for “£1,226” substitute “£1,279”.
In paragraph (5C)—
in sub-paragraph (a), for “£2,452” substitute “£2,557”; and
in sub-paragraph (b), for “£1,226” substitute “£1,279”.
Signature
Signed by authority of the Secretary of State for Health.
Dawn Primarolo
Minister of State,
Department of Health
9th February 2009
We consent
Tony Cunningham
Dave Watts
Two of the Lords Commissioners of Her Majesty’s Treasury
23rd February 2009
Explanatory note
(This note is not part of the Regulations)
These Regulations amend the Blood Safety and Quality Regulations 2005 (S.I.2005/50) (“the principal Regulations”), which implement Directive 2002/98/EC of the European Parliament and of the Council setting out the standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsf1 and related Commission Directivesf2.
Regulation 2 amends regulation 22 of the principal Regulations to increase the fees payable by blood establishments and hospital blood banks or facilities in relation to authorisation, operation, and haemovigilance. The overall average fee increase is around 4%.
An impact assessment of the effect that this instrument will have on the costs of the business is available from the Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.